English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Mar 25, 2026

AstraZeneca announces Shanghai cell therapy manufacturing base to support China strategy
+ Pharmaceuticals
Patient Daily | Mar 25, 2026

Revolution and Ascendis identified as top buyout targets amid speculation of industry mega-merger
+ Pharmaceuticals
Patient Daily | Mar 25, 2026

FDA approves higher dose of Wegovy for weight loss under priority voucher program
+ Pharmaceuticals
Patient Daily | Mar 25, 2026

Opinion piece discusses challenges in ALS drug development and calls for policy changes
+ Pharmaceuticals
Patient Daily | Mar 25, 2026

Sarepta to seek full FDA approval for Duchenne therapies after failed confirmatory trial
+ Pharmaceuticals
Patient Daily | Mar 25, 2026

Lilly reports late-stage diabetes data for triple-G agonist retatrutide
+ Pharmaceuticals
Patient Daily | Mar 25, 2026

BioSpace report finds changing employers leads to higher salary increases in biopharma
+ Pharmaceuticals
Patient Daily | Mar 25, 2026

Gossamer Bio announces layoffs after late-stage trial failure in hypertension drug

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes